Published in Psychiatry Res on November 01, 1987
Prevention of eating disorders in at-risk college-age women. Arch Gen Psychiatry (2006) 2.19
Depression in primary care. Why do we miss the diagnosis? Can Fam Physician (1994) 1.33
Who is really at risk? Identifying risk factors for subthreshold and full syndrome eating disorders in a high-risk sample. Psychol Med (2011) 1.15
Line bisection performance in patients with generalized anxiety disorder and treatment-resistant depression. Int J Med Sci (2010) 0.82
Psychiatric co-morbidity in women presenting across the continuum of disordered eating. Eat Behav (2014) 0.80
Formal psychological assessment in evaluating depression: a new methodology to build exhaustive and irredundant adaptive questionnaires. PLoS One (2015) 0.77
Relationship between personality disorder functioning styles and the emotional states in bipolar I and II disorders. PLoS One (2015) 0.77
Predicting personality disorder functioning styles by the Chinese Adjective Descriptors of Personality: a preliminary trial in healthy people and personality disorder patients. BMC Psychiatry (2016) 0.75
Inhibitory brainstem reflexes under external emotional-stimuli in bipolar I and II disorders. BMC Psychiatry (2017) 0.75
Personality characteristics of male sufferers of chronic tension-type and cervicogenic headache. J Clin Neurol (2012) 0.75
A study of remitted and treatment-resistant depression using MMPI and including pessimism and optimism scales. PLoS One (2014) 0.75
Improving Major Depressive Episode Assessment: A New Tool Developed by Formal Psychological Assessment. Front Psychol (2017) 0.75
High cholesterol levels in patients with panic disorder. Am J Psychiatry (1992) 2.25
Interrelationships among anxiety, aggression, impulsivity, and mood: a serotonergically linked cluster? Psychiatry Res (1990) 1.59
[Depression following a first heart infarct; similarities with and differences from 'ordinary' depression]. Ned Tijdschr Geneeskd (1997) 1.43
Headache and cortisol responses to m-chlorophenylpiperazine are highly correlated. Cephalalgia (1993) 1.41
[Mania: clinical aspects, cause and treatment]. Ned Tijdschr Geneeskd (1994) 1.40
Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood. Neuropsychopharmacology (2002) 1.40
Plasma concentrations of diazepam and of its metabolite N-desmethyldiazepam in relation to anxiolytic effect. Clin Pharmacol Ther (1974) 1.23
Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol in cerebrospinal fluid. Biochem Pharmacol (1971) 1.23
Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation. Psychopharmacology (Berl) (1999) 1.22
Amitriptyline plasma-concentration and clinical effect. A World Health Organisation Collaborative Study. Lancet (1978) 1.19
Is there a relation between the seriousness of suicidal intent and the lethality of the suicide attempt? Psychiatry Res (1989) 1.18
Fluvoxamine and clomipramine in depressed patients. A double-blind clinical study. Acta Psychiatr Scand (1981) 1.05
Anxiety, impulsivity and depressed mood in relation to suicidal and violent behavior. Acta Psychiatr Scand (1993) 1.05
A self-report measure of violence risk, II. Compr Psychiatry (1990) 1.04
The role of serotonin in schizophrenia. Schizophr Bull (1988) 1.00
Significance of cocaine history in schizophrenia. J Nerv Ment Dis (1990) 0.99
Cerebral monoamines and depression. An investigation with the Probenecid technique. Arch Gen Psychiatry (1973) 0.99
5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature (1970) 0.98
Management of depression with serotonin precursors. Biol Psychiatry (1981) 0.97
Correlates of suicide and violence risk: III. A two-stage model of countervailing forces. Psychiatry Res (1989) 0.96
Depression. Lancet (1982) 0.94
Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res (1991) 0.92
Mood effects of 24-hour tryptophan depletion in healthy first-degree relatives of patients with affective disorders. Biol Psychiatry (1999) 0.91
The clinical significance of halopemide, a dopamine-blocker related to the butyrophenones. Neuropsychobiology (1984) 0.89
The role of serotonin in schizophrenia. Eur Neuropsychopharmacol (1995) 0.88
Retarded depression and the dopamine metabolism. Psychopharmacologia (1971) 0.88
Treatment of depression in Parkinson's disease: a meta-analysis. J Neuropsychiatry Clin Neurosci (1995) 0.86
The therapeutic effect of short-term oral diazepam treatment on acute clinical anxiety in a crisis centre. Acta Psychiatr Scand (1974) 0.86
A controlled study of temporal lobe structure volumes and P300 responses in schizophrenic patients with persistent auditory hallucinations. Schizophr Res (1999) 0.86
Specificity of the tryptophan depletion method. Psychopharmacology (Berl) (1999) 0.86
Neuroleptics as a guideline to biological research in psychotic disorders. Compr Psychiatry (1975) 0.85
Serotonin and anxiety revisited. Biol Psychiatry (1988) 0.85
Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side-effects. Int Clin Psychopharmacol (1996) 0.85
Correlates of suicide and violence risk 1: the suicide risk measure. Compr Psychiatry (1989) 0.84
Kinetics of l-5-hydroxytryptophan in healthy subjects. Psychiatry Res (1982) 0.84
A pilot study of some kinetic aspects of the metabolism of 5-hydroxytryptamine in depressive patients. Biol Psychiatry (1971) 0.84
Correlates of risk of suicide in violent and nonviolent psychiatric patients. Am J Psychiatry (1991) 0.84
Central serotonin metabolism and frequency of depression. Psychiatry Res (1979) 0.84
Serotonin syndrome after challenge with the 5-HT agonist meta-chlorophenylpiperazine. Psychiatry Res (1998) 0.82
Suicidal behaviors in adult psychiatric outpatients, I: Description and prevalence. Am J Psychiatry (1993) 0.82
Central monoamine deficiency in depressions: causative of secondary phenomenon? Pharmakopsychiatr Neuropsychopharmakol (1975) 0.82
The vital syndrome interview. A structured standard interview for the recognition and registration of the vital depressive symptom complex. Psychiatr Neurol Neurochir (1966) 0.82
Fluphenazine enanthate and fluphenazine decanoate: a comparison of their duration of action and motor side effects. Am J Psychiatry (1973) 0.82
The MCPP challenge test in schizophrenia: hormonal and behavioral responses. Biol Psychiatry (1991) 0.82
Cerebrospinal fluid 5-hydroxyindolacetic acid and aggression: a critical reappraisal of the clinical data. Int Clin Psychopharmacol (1995) 0.82
Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder. Psychopharmacology (Berl) (1988) 0.81
The influence of probenecid on the metabolism of serotonin, dopamine and their precursors in man. Psychopharmacologia (1973) 0.81
Effects of tryptophan depletion on anxiety and on panic provoked by carbon dioxide challenge. Psychiatry Res (1998) 0.80
Behavioral indications for serotonin receptor hypersensitivity in panic disorder. Psychiatry Res (1988) 0.80
The effect of stress on the dexamethasone suppression test. Psychiatry Res (1985) 0.80
Neurological signs and the positive-negative dimension in schizophrenia. Biol Psychiatry (1990) 0.80
Suicide and violence associated with panic attacks. Biol Psychiatry (1992) 0.80
CSF 5-HIAA and suicide in non-depressed schizophrenics. Lancet (1983) 0.79
Determination of clomipramine and desmethylclomipramine in plasma by means of liquid chromatography. J Chromatogr (1977) 0.79
The origin of CSF choline and its relation to acetylcholine metabolism in brain. Life Sci (1979) 0.79
The effect of L-dopa and propranolol on human CSF cyclic nucleotides. Psychopharmacology (Berl) (1978) 0.79
Concerns about depression. Eur Psychiatry (1995) 0.79
Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: A biochemical classification? Psychopharmacologia (1971) 0.79
Biological suicide research: outcome and limitations. Biol Psychiatry (1986) 0.79
The neuroendocrine challenge paradigm in headache research. Cephalalgia (1995) 0.79
Measurement of aggression in psychiatric patients. Psychiatry Res (1997) 0.79
Central monoamine metabolism in depressions. I. Serotonin and related compounds. Compr Psychiatry (1980) 0.79
In search of the mode of action of antidepressants. 5-HTP/tyrosine mixtures in depressions. Neuropharmacology (1983) 0.78
Biochemical research into psychosis. Acta Psychiatr Scand (1975) 0.78
Effect of tyrosine on attention deficit disorder with hyperactivity. J Clin Psychiatry (1988) 0.78
Clinical significance of probenecid test. Lancet (1973) 0.78
Effects of m-chlorophenylpiperazine in normal subjects: a dose-response study. Psychopharmacology (Berl) (1990) 0.78
The neuroendocrine response to fenfluramine in depressives and normal controls. Biol Psychiatry (1988) 0.78
Hypersensitivity to m-chlorophenylpiperazine in a subject with subclinical panic attacks. Biol Psychiatry (1990) 0.78
Predicting response to levodopa. Lancet (1971) 0.78
Functional interrelationship of serotonin and norepinephrine: cortisol response to MCPP and DMI in patients with panic disorder, patients with depression, and normal control subjects. Psychiatry Res (1992) 0.78
The use of the synthetic peptides gamma-type endorphins in mentally ill patients. Ann N Y Acad Sci (1982) 0.78
Chemoprophylaxis of depressions. An attempt to compare lithium with 5-hydroxytryptophan. Acta Psychiatr Scand Suppl (1981) 0.78
Neuroendocrine disorders in depressions and their significance for the monoamine hypothesis of depression. Acta Psychiatr Scand (1978) 0.77
Central serotonin deficiency--a factor which increases depression vulnerability? Acta Psychiatr Scand Suppl (1980) 0.77
An attempt at indirect evaluation of the noradrenaline hypothesis. Results of a pilot study of the antidepressive qualities of p-chloro-N-methylamphetamine. Behav Neuropsychiatry (1969) 0.77
Homicidal behaviors among psychiatric outpatients. Hosp Community Psychiatry (1994) 0.77
Negative symptoms in schizophrenia: considerations for clinical trials. Working group on negative symptoms in schizophrenia. Psychopharmacology (Berl) (1994) 0.77
Toward a biochemical classification of depression. Adv Biochem Psychopharmacol (1974) 0.77
Therapeutic indications for serotonin-potentiating compounds: a hypothesis. Biol Psychiatry (1987) 0.77
Pharmacokinetics of clomipramine in depressive patients. Psychiatry Res (1981) 0.77
A controlled comparative study of fluphenazine and fluphenazine enanthate in acute and chronic psychotic patients. Psychiatr Neurol Neurochir (1970) 0.77
Serotonin precursors in the treatment of depression. Adv Biochem Psychopharmacol (1982) 0.77
Parental loss and family violence as correlates of suicide and violence risk. Suicide Life Threat Behav (1995) 0.77
Itinerary: Concerning the professional and spiritual objectives of my life. Med Humanit (2003) 0.77
Improvement of schizophrenic patients treated with [des-Tyr1]-gamma-endorphin (DTgammaE). Arch Gen Psychiatry (1979) 0.76
The significance of dopamine for the mode of action of neuroleptics and the pathogenesis of schizophrenia. Br J Psychiatry (1977) 0.76
Psychological test characteristics of depressed and panic patients. Psychiatry Res (1990) 0.76
The intravenous probenecid test: a possible aid in evaluation of the serotonin hypothesis on the pathogenesis of depressions. Psychopharmacologia (1970) 0.76
Effects of serotonin antagonists on m-chlorophenylpiperazine-mediated responses in normal subjects. Psychiatry Res (1990) 0.76
Cortisol response to intramuscular desipramine in patients with major depression and normal control subjects: a replication study. Psychiatry Res (1992) 0.76
In vivo electrochemical and behavioral evidence for specific neural substrates modulated differentially by enkephalin in rat stimulant stereotypy and locomotion. Biol Psychiatry (1984) 0.76
The role of serotonin in schizophrenia. New findings. Schizophr Res (1991) 0.76
Effects of alprazolam on increases in hormonal and anxiety levels induced by meta-chlorophenylpiperazine. Psychiatry Res (1994) 0.76
About the impossible concept of schizophrenia. Compr Psychiatry (1976) 0.76
Hormonal probes of central serotonergic activity: do they really exist? Biol Psychiatry (1987) 0.76
High-dose naloxone in tardive dyskinesia. Psychiatry Res (1988) 0.76
Serotonin receptor sensitivity in major depression. Biol Psychiatry (1990) 0.76
Correlates of suicide and violence risk in an inpatient population: coping styles and social support. Psychiatry Res (1993) 0.76